Thrombo-inflammation

Cardiovascular diseases are a major cause of morbidity and mortality and disproportionately affects ethnic minority groups and those socioeconomically deprived. The interplay between inflammation and thrombosis (thrombo-inflammation) plays a critical role in nearly all vascular and heart diseases, and represents a major target for clinical interventions. Moreover, vascular events are a significant driver of prognosis across all chronic inflammatory diseases. Our thrombo-inflammation theme will improve our ability to intercede in clotting whilst avoiding excess bleeding, target underlying inflammatory processes, identify novel biomarkers of thrombo-inflammatory disease, and use artificial intelligence (AI) and innovative trial designs to translate research to better patient care.

Red blood cells

Theme Leads

Portrait picture of Steve Watson

Professor Steve Watson

Portrait picture of Dipak Kotecha

Professor Dipak Kotecha

Related news

Birmingham Platelet Group recognised in 2023 Pharmaceutical Technology Excellence Awards

Researchers led by NIHR Birmingham Biomedical Research Centre (BRC) members Professor Steve Watson and Dr Eleyna

Birmingham Platelet Group delivers breakthrough ‘nanobody’ technology

Birmingham researchers created antibody fragments called nanobodies to help scientists understand more about platelet disorders such

Patients with Atrial High-Rate Episodes should not be treated with anticoagulant, trial finds

A trial involving Birmingham researchers showed that patients with atrial high-rate episodes (AHREs) detected by implanted